Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation
- 1 June 2004
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 151 (2) , 152-156
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancerHuman Mutation, 2003
- Correlation Between Morphology, Immunohistochemistry and Molecular Pathology in Hereditary and Sporadic Breast Cancer CasesUltrastructural Pathology, 2002
- BRCA1 mutation analysis in breast/ovarian cancer families from GreeceHuman Mutation, 2000
- A survey of the current clinical facilities for the management of familial cancer in EuropeJournal of Medical Genetics, 2000
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populationsHuman Molecular Genetics, 1996
- A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypesNature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individualsNature Genetics, 1995
- BRCA1 Mutations in Primary Breast and Ovarian CarcinomasScience, 1994